A phase II study of amrubicin combined with carboplatin for elderly patients with small-cell lung cancer: North Japan Lung Cancer Study Group Trial 0405Akira Inoue, T. Nukiwa, Shinji Ogura et al.|Annals of Oncology|2009Cited by 37
Randomized phase II trial of weekly paclitaxel combined with carboplatin versus standard paclitaxel combined with carboplatin for elderly patients with advanced non-small-cell lung cancerTomohiro Sakakibara, T. Nukiwa, Akira Inoue et al.|Annals of Oncology|2009Cited by 36
Randomized phase II study of carboplatin plus irinotecan versus carboplatin plus amrubicin in patients with chemo-naïve extensive-stage small-cell lung cancer: North Japan Lung Cancer Study Group (NJLCG) 0901Naoto Morikawa, Toshihiro Nukiwa, Akira Inoue et al.|Lung Cancer|2017Cited by 9
Randomized phase II trial of daily administration versus alternate-day administration of S-1 in patients with advanced non-small cell lung cancerAya Suzuki, Toshihiro Nukiwa, Makoto Maemondo et al.|Cancer Treatment and Research Communications|2017Cited by 6